Health Catalyst, Inc. has filed an 8-K report detailing a transition agreement with Daniel Burton, who recently stepped down as CEO. The agreement, effective March 31, 2026, allows Burton to continue as a strategic advisor until December 31, 2026, with a monthly salary of $10,000. This arrangement aims to ensure a smooth transition of responsibilities following his early retirement announcement on February 12, 2026. As part of the agreement, Burton will forfeit all unvested stock units and performance-based restricted stock units. The transition agreement is designed to facilitate continuity in leadership and operational execution during this period of change. The full text of the transition agreement is available as an exhibit in the filing.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.